Crossref indexed
Expert Review of Pharmacoeconomics & Outcomes Research
Published by Informa UK (Taylor & Francis).
ISSN 1473-7167 / 1744-8379
Submit to this journal
01
Aims & scope
Expert Review of Pharmacoeconomics & Outcomes Research publishes peer-reviewed research. Manuscripts pass a technical check and a scope check by the handling editor before going to independent reviewers.
02
Recently published
Expert review of pharmacoeconomics and outcomes Research: high impact articles from 2025
DOI 10.1080/14737167.2026.2752198 Tamas Agh, Mickael Hiligsmann, Carolyn Gotay, Jayashri Sankaranarayanan, Carlo Lazzaro, Katarzyna Kolasa, Steven Simoens, Lieke Maas, Ryan Gilroy · 2026
Assessing health related quality of life of patients on maintenance hemodialysis in north-western Morocco
DOI 10.1080/14737167.2026.2753082 Rania Mourchid, Amal Yassine, Yahia Cherrah, Samira Serragui · 2026
Cost-utility of expanded hypertension screening and treatment among adults covered by Peru’s Seguro Integral de Salud: a Markov model using national data
DOI 10.1080/14737167.2026.2751401 Víctor Juan Vera-Ponce, Jhosmer Ballena-Caicedo · 2026
Machine learning in comparative effective research of pharmacological interventions: a scoping review
DOI 10.1080/14737167.2026.2746821 Zhen Wang, Bijan J. Borah · 2026
Cost-effectiveness of amivantamab plus lazertinib and osimertinib plus chemotherapy versus osimertinib monotherapy for first-line EGFR-mutated advanced non-small cell lung cancer: an updated analysis
DOI 10.1080/14737167.2026.2746857 Pooja Gokhale, Joshua Caballero, Niying Li, Lorenzo Villa Zapata · 2026
Defining value criteria for outcomes-based managed entry agreements in CAR-T therapy for relapsed/refractory multiple myeloma: a multi-criteria decision analysis study
DOI 10.1080/14737167.2026.2739076 María Victoria Mateos Manteca, José Luis Poveda Andrés, Albert Oriol Rocafiguera, Vicente Escudero-Vilaplana, José Luis Trillo Mata, Pedro Gómez Pajuelo, Alberto Arribas Ruiz, Teresa Domínguez Lubillo, Neus Vidal-Vilar, Asís Ariznavarreta Martín · 2026
The presence of prior-effects of the Medicaid expansion on drug prescription
DOI 10.1080/14737167.2026.2746156 Andrew Kim, Taisuke Sadayuki · 2026
Cost-effectiveness of RIMS1 methylation-guided gastric cancer surveillance after
<i>Helicobacter pylori</i>
eradication
DOI 10.1080/14737167.2026.2746232 Yifan Qiu, Xianzhu Zhou, Hao Hu, Shudan Chen, Xinhui Zhan, Jingmin Feng, Xinyi Cai, Tuo Li, Jing Zhang, Yiqi Du, Jiafeng Zhang · 2026
Cost-effectiveness of microaxial flow pump versus standard of care in the management of Cardiogenic shock in Spain
DOI 10.1080/14737167.2026.2743886 Rut Andrea, Alfonso Jurado-Román, Sandra O. Rosillo, Juan Bustamante-Munguira, Jose F. Diaz, Maria Generosa Crespo-Leiro, Rocío González-Alonso Del Hoyo, Itziar Oyagüez, Nuria Garcia, Lorine Foux, Stylianos Tsintzos, Maria Presa · 2026
Wholesale, pharmacy mark-up, and retail price dynamics under a declaration-based medicine pricing reform in Kosovo
DOI 10.1080/14737167.2026.2746142 Toskë Kryeziu, Mimoza Basholli Salihu, Venesa Lupçi, Ufuk Bağcı, Aida Loshaj Shala · 2026
Correction
DOI 10.1080/14737167.2026.2744040 Authors not listed · 2026
Clinical and economic benefits of bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for prevention of RSV in adults: a cost-effectiveness analysis for Singapore
DOI 10.1080/14737167.2026.2737558 Karan Thakkar, Ali Shajarizadeh, Nishu Gaind, Luka Ivkovic, Gopika Balasubramanian, Rengina Kefalogianni, Jessie Zhang, Kay Choong See, Andrea Lay-Hoon Kwa, Diana Mendes · 2026
Journal metrics
Total DOIs2,346
Current DOIs349
Backfile DOIs1,997
Published here0
Publish with us
Five steps, about 15 minutes. You can save and come back at any point.
Submit manuscript